about
Angiographic and intravascular ultrasound follow up of paclitaxel- and sirolimus-eluting stent after poststent high-pressure balloon dilation: from the poststent optimal stent expansion trial.Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients.Clinical Implication of Optical Coherence Tomography-Based Neoatherosclerosis.Optical coherence tomographic observation of morphological features of neointimal tissue after drug-eluting stent implantationImpact of statin treatment on strut coverage after drug-eluting stent implantation.Short- versus long-term dual antiplatelet therapy after drug-eluting stent implantation: an individual patient data pairwise and network meta-analysis.Correlations between coronary plaque tissue composition assessed by virtual histology and blood levels of biomarkers for coronary artery disease.Comparison of optical coherence tomographic assessment between first- and second-generation drug-eluting stentsComparison between measured and calculated length of side branch ostium in coronary bifurcation lesions with intravascular ultrasound.Serial plasma levels of angiogenic factors in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.Arterial occlusive disease complicating radiation therapy of cervical cancer.The first korean patient with severe aortic stenosis and bilateral iliofemoral artery disease treated with transcatheter aortic valve implantation by transsubclavian approachPercutaneous Coronary Intervention Is More Beneficial Than Optimal Medical Therapy in Elderly Patients with Angina Pectoris.Comparison of early clinical outcomes following transcatheter aortic valve implantation versus surgical aortic valve replacement versus optimal medical therapy in patients older than 80 years with symptomatic severe aortic stenosisPreventive effect of pretreatment with intravenous nicorandil on contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography (PRINCIPLE Study).Mechanisms of stent thrombosis: insights from optical coherence tomographyEarly Effects of Intensive Lipid-Lowering Treatment on Plaque Characteristics Assessed by Virtual Histology Intravascular Ultrasound.Development of a New Hybrid Biodegradable Drug-Eluting Stent for the Treatment of Peripheral Artery DiseaseProspective and systematic analysis of unexpected requests for non-cardiac surgery or other invasive procedures during the first year after drug-eluting stent implantation.The Effect of Sex and Anthropometry on Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention for Complex Coronary Lesions.Comparison of full lesion coverage versus spot drug-eluting stent implantation for coronary artery stenoses.Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation.Stent evaluation with optical coherence tomography.High-intensity Statin Treatments in Clinically Stable Patients on Aspirin Monotherapy 12 Months After Drug-eluting Stent Implantation: A Randomized Study.Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trials.A newly formed and ruptured atheromatous plaque within neointima after drug-eluting stent implantation: 2-year follow-up intravascular ultrasound and optical coherence tomography studies.Drug-eluting stents to prevent stent thrombosis and restenosis.Bleeding-Related Deaths in Relation to the Duration of Dual-Antiplatelet Therapy After Coronary Stenting.Nobori-Biolimus-Eluting Stents versus Resolute Zotarolimus-Eluting Stents in Patients Undergoing Coronary Intervention: A Propensity Score Matching.Clinical Feasibility of 3D Automated Coronary Atherosclerotic Plaque Quantification Algorithm on Coronary Computed Tomography Angiography: Comparison with Intravascular Ultrasound.Outcomes of the single-stent versus kissing-stents technique in asymmetric complex aortoiliac bifurcation lesions.Association Between Duration of Dual Antiplatelet Therapy and Angiographic Multivessel Disease on Outcomes in Patients Treated With Newer-Generation Drug-Eluting Stents.Intravascular Ultrasound Predictors of Major Adverse Cardiovascular Events After Implantation of Everolimus-eluting Stents for Long Coronary Lesions.Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI.Short-versus long-term Dual Antiplatelet therapy after drug-eluting stent implantation in women versus men: A sex-specific patient-level pooled-analysis of six randomized trials.Long-Term Clinical Outcomes of a Biodegradable Polymer-Based Biolimus-Eluting Stent.Retrograde distal superficial femoral artery approach in the supine position for chronic superficial femoral artery occlusion.Clinical outcomes of dual antiplatelet therapy after implantation of drug-eluting stents in patients with different cardiovascular risk factors.Transient New-Onset Atrial Fibrillation Is Associated With Poor Clinical Outcomes in Patients With Acute Myocardial Infarction.Renal denervation for treatment of uncontrolled hypertension in an Asian population: results from the Global SYMPLICITY Registry in South Korea (GSR Korea).
P50
Q30394624-284437B5-466E-456B-8A1A-F07F5D13EF33Q31155795-41BEC8F8-1648-4BC6-B61E-FD9DDD163471Q33770283-BB39983B-A0FC-4F4F-AFA6-2BBE1F21748AQ33822577-212F12D5-63E5-403B-B0F2-4327CD901D59Q34774239-F9CA570F-1001-44EF-B609-352A49AB55B1Q35581671-7122BBE8-48A5-40FE-8316-4689713DD473Q35932082-67E84176-3DB1-4523-89D7-6E1A2B63D09CQ35932110-7DCB8E7F-AD22-4E95-84A4-69702ABBEC2BQ36053467-3B18CE4D-0D0D-4A71-9D96-064EF1037131Q36131400-5FAC4138-C45A-4601-976E-7E20E9B49B24Q36348023-D27B1970-6E1D-464E-A957-8D44E433396FQ36457145-DD86CB13-2972-4D52-9D4F-3B4107FB161BQ36541569-2ED3CF37-6DC6-44EF-8233-C1089B8E0C75Q36793079-D404723F-E517-464F-9CF7-C20ABC1F7E60Q36872875-CF98372B-2408-444A-A1C6-F7D4CAB28512Q36949011-AFE26A47-1AA9-4744-9282-4C82DF51B502Q37124751-662A6B23-0A2B-4D67-BA58-13B96FE90A36Q37483241-750305D3-AB42-421F-B0A1-A9AD2191B525Q37606698-09F04141-88D0-4DDC-9DC2-0D8CA5A28C65Q37622133-0B74C22C-D8C1-4D4D-8073-73619B096949Q37708244-BF4F82F0-5F59-4D69-9695-3F575324CFC3Q38063290-FF57400F-B00E-4A67-94A2-BA8B06042B63Q38126880-C068F739-A773-4B75-85EF-525F79F30986Q38373800-506A8B9D-CCDD-4DF5-94D7-CC7A4CA99B44Q38380479-EDA35FA0-3B1A-4087-9CA5-21D68EBEF3E2Q38469243-45479A07-4E7D-46F2-8E29-6D39ECE648ABQ38633332-1E7D59B8-9E54-460F-94E0-C0E8AC5ABAA8Q38828111-0DA66CE9-48B9-4E99-ABAF-3FD08593A242Q39000577-20FC6ABD-6B4D-45EF-9A1A-9276423495B1Q39004406-843689EB-0EBC-4C26-BA7E-4BFFDAE9F97BQ39009657-635CF948-FE05-4D9F-98E8-B5A50F61692CQ39226323-8818C5D1-DC92-4749-A870-7B34BECFF32AQ39242253-F64E3235-0840-4586-8FFC-769848F54908Q39422154-DDE5194F-37EC-4439-9B5B-57E57A161B54Q39592831-870E395F-60A4-4864-A66F-2F2F15377692Q39959015-6C5BD4B3-CC80-4BA3-B323-C02D19497DE9Q40031453-CD69E773-0C72-484E-99D3-1974A7C9306DQ40580110-9BA16AEF-7170-4016-AC75-4B2EAA55E67AQ40742476-69E6E71E-9706-4C58-8919-9523C1C1A641Q40757395-4F6BECE5-61F8-48F2-B0E4-FE911CB1DE24
P50
description
researcher ORCID ID = 0000-0002-2090-2031
@en
wetenschapper
@nl
name
Myeong-Ki Hong
@ast
Myeong-Ki Hong
@en
Myeong-Ki Hong
@es
Myeong-Ki Hong
@nl
type
label
Myeong-Ki Hong
@ast
Myeong-Ki Hong
@en
Myeong-Ki Hong
@es
Myeong-Ki Hong
@nl
prefLabel
Myeong-Ki Hong
@ast
Myeong-Ki Hong
@en
Myeong-Ki Hong
@es
Myeong-Ki Hong
@nl
P106
P31
P496
0000-0002-2090-2031